Ozonation of reverse osmosis concentrate: Kinetics and efficiency of beta blocker oxidation

Reverse osmosis (RO) concentrate samples were obtained from a RO-membrane system that uses effluents of wastewater treatment plants (WWTP) as feed water for the production of drinking water. A number of different pharmaceuticals (e.g. antibiotics, contrast media, beta blockers) were found in the WWTP effluent as well as in the RO-concentrate. Overall, a concentration factor (feed: concentrate) of approximately 3-4 was measured. Beta blockers (acebutolol, atenolol, bisoprolol, celiprolol, metoprolol, propranolol, timolol) were found in the range of low ng/L to low mu g/L. Because metoprolol and propranolol are classified as potentially toxic to aquatic organisms and all beta blocker molecules have moieties, which are reactive towards ozone (amine groups, activated aromatic rings), it was tested whether ozonation can be applied for their mitigation. Rate constants for the reaction of acebutolol, atenolol, metoprolol and propranolol with ozone and OH radicals were determined. At pH 7 acebutolol, atenolol and metoprolol react with ozone with an apparent second-order rate constant (ko(3)) of about 2000 M-1 s(-1), whereas propranolol reacts with similar to 10(5)M(-1)s(-1). The rate constants for the reaction of the selected compounds with (OH)-O-center dot radicals were determined to be 0.5-1.0 x 10(10)M(-1) s(-1). Experiments with RO concentrate showed that an ozone dose of only 5 mg/L resulted in a quantitative removal of propranolol in 0.8s and 10 mg O-3/L, oxidized 70% of metoprolol in only 1.2s. Tests with chlorinated and non-chlorinated WWTP effluent showed an increase of ozone stability but a decrease of hydroxyl radical exposure in the samples after chlorination. This may shift the oxidation processes towards direct ozone reactions and favor the degradation of compounds with high kO(3). (C) 2008 Elsevier Ltd. All rights reserved.

Published in:
Water Research, 42, 3003-3012

 Record created 2011-07-01, last modified 2018-03-17

Rate this document:

Rate this document:
(Not yet reviewed)